pyrroles has been researched along with mifepristone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischbach, PS; Rice, KC; Savit, AZ; Verhoeven, RE; Wood, SK; Woods, JH | 1 |
| Brown, BE; Choi, EH; Crumrine, D; Demerjian, M; Elias, PM; Feingold, KR; Mauro, T | 1 |
| Lu, CC; Tsai, SC | 1 |
| Burkhart-Kasch, S; Coste, SC; McKinnon, CS; Pastor, R; Phillips, TJ; Reed, C; Ryabinin, AE; Scibelli, AC; Stenzel-Poore, MP | 1 |
| Hodge, CW; Lowery, EG; Lyons, AM; Navarro, M; Spanos, M; Thiele, TE | 1 |
| Cheung, LW; Leung, KW; Wong, AS; Wong, CK; Wong, RN | 1 |
| Abid Masood, M; Bazin, M; Bunnage, ME; Fancy, SA; Farrant, E; Morao, I; Peakman, T; Perez, M | 1 |
| Li, JS; Mei, YY | 1 |
| Groenink, L; Millan, MJ; Peeters, BW; van Esterik, JC; Verdouw, PM | 1 |
| Okada, H; Yasuda, K; Yoshida, A | 1 |
10 other study(ies) available for pyrroles and mifepristone
| Article | Year |
|---|---|
Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats.
Topics: Animals; Bradycardia; Cholinergic Antagonists; Corticotropin-Releasing Hormone; Death, Sudden, Cardiac; Disease Models, Animal; Exercise Tolerance; Fatigue; Heart Rate; Hypothalamo-Hypophyseal System; Hypothermia, Induced; Male; Mifepristone; Peptide Fragments; Psychomotor Agitation; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stress, Psychological; Swimming; Vagus Nerve; Vagus Nerve Diseases | 2006 |
Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function.
Topics: Animals; Dose-Response Relationship, Drug; Epidermis; Female; Glucocorticoids; Mice; Mice, Hairless; Mifepristone; Pyrimidines; Pyrroles; Skin Diseases; Stress, Psychological | 2006 |
The cyclic AMP-dependent protein kinase A pathway is involved in progesterone effects on calcitonin secretion from TT cells.
Topics: 1-Methyl-3-isobutylxanthine; Adenine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Blotting, Western; Calcitonin; Carbazoles; Cell Line, Tumor; Cell Nucleus; CREB-Binding Protein; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Antibody Technique; Gene Expression; Humans; Indoles; Mifepristone; Progesterone; Progestins; Pyrroles; Receptors, Progesterone; RNA, Messenger; Signal Transduction; Time Factors | 2007 |
Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism.
Topics: Adaptation, Biological; Adrenocorticotropic Hormone; Animals; Behavior, Animal; Ethanol; Gene Deletion; Mice; Mice, Inbred C57BL; Mice, Knockout; Mifepristone; Nervous System Physiological Phenomena; Psychomotor Performance; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Urocortins | 2008 |
CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Corticotropin-Releasing Hormone; Disease Models, Animal; Hormone Antagonists; Hypothalamo-Hypophyseal System; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Mifepristone; Peptide Fragments; Pyridines; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Signal Transduction; Urocortins | 2010 |
Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1.
Topics: Angiogenesis Inducing Agents; Cells, Cultured; Endothelial Cells; Enzyme Activation; Ginsenosides; Hormone Antagonists; Humans; Mifepristone; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Receptor Cross-Talk; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Glucocorticoid; RNA Interference | 2011 |
Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8.
Topics: Biomimetics; Carbon; Chemistry, Pharmaceutical; Chlorine; Drug Design; Humans; Hydrogen; Inhibitory Concentration 50; Metalloporphyrins; Metals; Microsomes, Liver; Mifepristone; Models, Chemical; Oxygen; Pyrimidines; Pyrroles; Structure-Activity Relationship | 2012 |
Involvements of stress hormones in the restraint-induced conditioned place preference.
Topics: Animals; Association Learning; Conditioning, Operant; Corticosterone; Male; Mifepristone; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Stress, Physiological | 2013 |
CRF
Topics: Animals; Anti-Anxiety Agents; Benzodioxoles; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Drug Interactions; Guinea Pigs; Maternal Deprivation; Mice; Mice, Transgenic; Mifepristone; Paroxetine; Pyridines; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid; Steroids; Vocalization, Animal | 2017 |
Conflicting Nongenomic Effects of Progesterone in the Myometrium of Pregnant Rats.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Female; Hormone Antagonists; Mifepristone; Myometrium; Nifedipine; Organ Culture Techniques; Oxytocin; Potassium Chloride; Pregnancy; Progesterone; Pyrroles; Rats, Wistar; Uterine Contraction; Verapamil | 2021 |